Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, September 1 2014 9:50am ET - U.S. Markets close in 6 hours and 10 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drugs - Generic
Composite Value: 1349.4
Today's Change: -0.38%
S&P 500: +0.33%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galectin Therapeutics, Inc. (GALT) To Contact The Firm
Fri Aug 29 (PR Newswire)
NEW YORK, Aug. 29, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Galectin Therapeutics, Inc. ("Galectin" or the "Company") (GALT) of the September 29, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Galectin and certain executives. The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects. Specifically, the action alleges that during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Galectin paid stock promoters to distribute positive but false reports about the Company's prospects;
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA - (PR Newswire)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT - (PR Newswire)
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
LANSEN PHARMA [0503.HK] +13.65% $0
Agile Therapeutics, Inc. [AGRX] +9.61% $156.9 M
Aquinox Pharmaceuticals, Inc. [AQXP] +7.46% $87.8 M
Parnell Pharmaceuticals Holding [PARN] +7.37% $49.5 M
SCYNEXIS, Inc. [SCYX] +6.31% $58.7 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
SUN PHARMACE [SUNPHARMA.BO] -1.46% $1773.5 B
LUPIN LTD [LUPIN.BO] +0.19% $577.1 B
LUPIN LIMITED [LUPIN.NS] +0.35% $576.3 B
DR.REDDYS L [DRREDDY.BO] +1.02% $502.7 B
DR REDDY'S LAB DEPO SETT. [DRREDDY.NS] +0.95% $502.1 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
09/10/14 APH.L Half Year 2014 Alliance Pharma PLC Earnings Release
10/22/14 ORX.ST Orexo AB Q3 2014 Earnings Release
10/28/14 SAN.PA Sanofi SA Q3 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/14/14 AGRX Agile Therapeutics, Inc. upside earnings surprise (+24.32%)
08/14/14 GUD.TO KNIGHT THERAPEUTICS INC upside earnings surprise (+200.00%)
08/14/14 FLXN Flexion Therapeutics, Inc. coverage initiated by Summer Street Research
More Recent Events...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
Accelerated Study Start
Clinical trial site identification, feasibility, and activation.
www.ePharmaSolutions.com
M/A/R/C Research
Full-service marketing research solutions customized to your needs
www.MARCresearch.com
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:7,096B
Price / Earnings:66.8
Price / Book:-18.9
Net Profit Margin (mrq):6.8%
Price To Free Cash Flow (mrq):-71.9
Return on Equity:24.6%
Total Debt / Equity:48.7
Dividend Yield:0.6%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
SRLS
GNVC
WPI
Unusually Active Boards
Board Variance
SRLS
GNVC
WPI

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?